Compare TEL & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEL | BDX |
|---|---|---|
| Founded | 1941 | 1897 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.9B | 51.5B |
| IPO Year | 2007 | 1997 |
| Metric | TEL | BDX |
|---|---|---|
| Price | $221.31 | $149.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $257.27 | $186.00 |
| AVG Volume (30 Days) | 2.5M | ★ 2.9M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | 1.38% | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.42 | 0.25 |
| Revenue | $17,262,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $7.74 | $3.02 |
| P/E Ratio | ★ $40.29 | $582.44 |
| Revenue Growth | ★ 8.94 | 8.24 |
| 52 Week Low | $162.17 | $141.82 |
| 52 Week High | $252.56 | $213.08 |
| Indicator | TEL | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 60.65 | 50.71 |
| Support Level | $212.50 | $141.82 |
| Resistance Level | $247.70 | $150.74 |
| Average True Range (ATR) | 5.84 | 3.65 |
| MACD | 2.15 | 0.51 |
| Stochastic Oscillator | 87.67 | 65.94 |
TE Connectivity is the largest electrical connector supplier in the world, supplying interconnect and sensor solutions to the transportation, industrial, and communications markets. With operations in 150 countries and over 500,000 stock-keeping units, TE has a broad portfolio that forms the electrical architecture of its end customers' cutting-edge innovations.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.